Models, Economic

"Models, Economic" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Statistical models of the production, distribution, and consumption of goods and services, as well as of financial considerations. For the application of statistics to the testing and quantifying of economic theories MODELS, ECONOMETRIC is available.

Descriptor ID	D018803
MeSH Number(s)	E05.318.740.500.600 E05.599.835.890 N05.715.360.750.530.500 N06.850.520.830.500.600
Concept/Terms	Models, Economic Models, Economic Economic Models Economic Model Model, Economic

Below are MeSH descriptors whose meaning is more general than "Models, Economic".

Analytical, Diagnostic and Therapeutic Techniques and Equipment [E]
Investigative Techniques [E05]
Epidemiologic Methods [E05.318]
Statistics as Topic [E05.318.740]
Models, Statistical [E05.318.740.500]
Models, Economic [E05.318.740.500.600]
Models, Theoretical [E05.599]
Models, Statistical [E05.599.835]
Models, Economic [E05.599.835.890]
Health Care [N]
Health Care Quality, Access, and Evaluation [N05]
Quality of Health Care [N05.715]
Health Care Evaluation Mechanisms [N05.715.360]
Statistics as Topic [N05.715.360.750]
Models, Statistical [N05.715.360.750.530]
Models, Economic [N05.715.360.750.530.500]
Environment and Public Health [N06]
Public Health [N06.850]
Epidemiologic Methods [N06.850.520]
Statistics as Topic [N06.850.520.830]
Models, Statistical [N06.850.520.830.500]
Models, Economic [N06.850.520.830.500.600]

Below are MeSH descriptors whose meaning is related to "Models, Economic".

Below are MeSH descriptors whose meaning is more specific than "Models, Economic".

Models, Economic
Models, Econometric

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Models, Economic" by people in this website by year, and whether "Models, Economic" was a major or minor topic of these publications.

Bar chart showing 7 publications over 7 distinct years, with a maximum of 1 publications in 2000 and 2001 and 2003 and 2004 and 2007 and 2015 and 2020

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
2000	0	1	1
2001	0	1	1
2003	0	1	1
2004	0	1	1
2007	0	1	1
2015	1	0	1
2020	0	1	1

Below are the most recent publications written about "Models, Economic" by people in Profiles.

Barber MRW, Hanly JG, Su L, Urowitz MB, St Pierre Y, Romero-Diaz J, Gordon C, Bae SC, Bernatsky S, Wallace DJ, Merrill JT, Isenberg DA, Rahman A, Ginzler EM, Petri M, Bruce IN, Dooley MA, Fortin PR, Gladman DD, Sanchez-Guerrero J, Steinsson K, Ramsey-Goldman R, Khamashta MA, Aranow C, Mackay M, Alarcón GS, Manzi S, Nived O, Jönsen A, Zoma AA, van Vollenhoven RF, Ramos-Casals M, Ruiz-Irastorza G, Lim SS, Kalunian KC, Inanc M, Kamen DL, Peschken CA, Jacobsen S, Askanase A, Farewell V, Stoll T, Buyon J, Clarke AE. Economic Evaluation of Damage Accrual in an International Systemic Lupus Erythematosus Inception Cohort Using a Multistate Model Approach. Arthritis Care Res (Hoboken). 2020 12; 72(12):1800-1808.

View in: PubMed
Grosse SD, Nelson RE, Nyarko KA, Richardson LC, Raskob GE. The economic burden of incident venous thromboembolism in the United States: A review of estimated attributable healthcare costs. Thromb Res. 2016 Jan; 137:3-10.

View in: PubMed
Yeh WS, Armstrong EP, Skrepnek GH, Malone DC. Peginterferon alfa-2a versus peginterferon alfa-2b as initial treatment of hepatitis C virus infection: a cost-utility analysis from the perspective of the Veterans Affairs Health Care System. Pharmacotherapy. 2007 Jun; 27(6):813-24.

View in: PubMed
Sullivan SD, Davidson BL, Kahn SR, Muntz JE, Oster G, Raskob G. A cost-effectiveness analysis of fondaparinux sodium compared with enoxaparin sodium as prophylaxis against venous thromboembolism: use in patients undergoing major orthopaedic surgery. Pharmacoeconomics. 2004; 22(9):605-20.

View in: PubMed
Sullivan SD, Kahn SR, Davidson BL, Borris L, Bossuyt P, Raskob G. Measuring the outcomes and pharmacoeconomic consequences of venous thromboembolism prophylaxis in major orthopaedic surgery. Pharmacoeconomics. 2003; 21(7):477-96.

View in: PubMed
Rogowski JA, Horbar JD, Plsek PE, Baker LS, Deterding J, Edwards WH, Hocker J, Kantak AD, Lewallen P, Lewis W, Lewit E, McCarroll CJ, Mujsce D, Payne NR, Shiono P, Soll RF, Leahy K. Economic implications of neonatal intensive care unit collaborative quality improvement. Pediatrics. 2001 Jan; 107(1):23-9.

View in: PubMed
Rich M, Scheiman JM, Tierney W, Fendrick AM. Is upper gastrointestinal radiography a cost-effective alternative to a Helicobacter pylori "test and treat" strategy for patients with suspected peptic ulcer disease? Am J Gastroenterol. 2000 Mar; 95(3):651-8.

View in: PubMed

People

Explore

Similar Concepts

Top Journals